Abstract
Multiple endocrine neoplasia type 1 (MEN1) is characterized by parathyroid, enteropancreatic endocrine and pituitary adenomas as well as germline mutation of the MEN1 gene. We describe 2 families with MEN1 with novel mutations in the MEN1 gene. One family was of Turkish origin, and the index patient had primary hyperparathyroidism (PHPT) plus a prolactinoma; three relatives had PHPT only. The index patient in the second family was a 46-yr-old woman of Chinese origin living in Taiwan. This patient presented with a complaint of epigastric pain and watery diarrhea over the past 3 months, and had undergone subtotal parathyroidectomy and enucleation of pancreatic islet cell tumor about 10 yr before. There was also a prolactinoma. Sequence analysis of the MEN1 gene from leukocyte genomic DNA revealed heterozygous mutations in both probands. The Turkish patient and her affected relatives all had a heterozygous A to G transition at codon 557 (AAG→ GAG) of exon 10 of MEN1 that results in a replacement of lysine by glutamic acid. The Chinese index patient and one of her siblings had a heterozygous mutation at codon 418 of exon 9 (GAC→TAT) that results in a substitution of aspartic acid by tyrosine. In conclusion, we have identified 2 novel missense mutations in the MEN1 gene.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gagel RF, Marx SJ. Multiple endocrine neoplasia. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS eds. Williams Textbook of Endocrinology. Philadelphia: W.B. Sauders. 2003, 1717–62.
Pannett AA, Thakker RV. Multiple endocrine neoplasia type 1. Endocr Relat Cancer 1999, 6: 449–73.
Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordensk-jold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988, 332: 85–7.
Guru SC, Olufemi SE, Manickam P. A 2.8-Mb clone contig of the multiple endocrine neoplasia type 1 region at 11 q13. Genomic 1997, 42: 436–45.
Lemmens I, Van de Ven WJ, Kas K, et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet 1997, 6: 1177–83.
Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia — type 1. Science 1997, 276: 404–7.
Guru SC, Goldsmith PK, Burns AL, et al. Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA 1998, 95: 1630–4.
Wautot V, Vercherat C, Lespinasse, et al. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. Hum Mutat 2002, 20: 35–47.
Kouvaraki MA, Lee JE, Shapiro SE, et al. Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Arch Surg 2002, 137: 641–7.
Brandi MI, Gagel RF, Angeli A, et al. Guideline for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86: 5658–71.
Agarwal SK, Kester MB, Debelenko LV, et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 1997, 6: 1169–75.
Poncin J, Abs R, Velkeniers B, et al. Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related disease. Hum Mutat 1999, 13: 54–60.
Mutch MG, Dilley WG, Sanjurjo F, et al. Germline mutations in the multiple endocrine neoplasia type 1 gene: evidence for frequent splicing defects. Hum Mutat 1999, 13: 175–85.
Cavaco BM, Domingues R, Bacelar MC, et al. Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions. Clin Endocrinol (Oxf) 2002, 56: 465–73.
Tso AW, Rong R, Lo CY, et al. Multiple endocrine neoplasia type 1 (MEN1): genetic and clinical analysis in the Southern Chinese. Clin Endocrinol (Oxf) 2002, 59: 129–35.
Jap TS, CY Chiu, JGS Won, YC Wu, Chen HS. Novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1. Clin Endocrinol (Oxf) 2005, 62: 336–42.
Hai N, Aoki N, Matsuda A, Mori T, Kosugi S. Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1. Eur J Endocrinol 1999, 141: 475–8
Guo SS, Sawicki MP. Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1. Mol Endocrinol 2001, 15: 1653–64.
Shepherd JJ. The natural history of multiple endocrine neoplasia type 1. Arch Surg 1991, 126: 935–52.
Turner JJ, Leotlela PD, Pannett AA, et al. Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2002, 87: 2688–93.
Gibril F, Venzon DJ, Ojeaburu JV, et al. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a non-aggressive from. J Clin Endocrinol Metab 2001, 86: 5282–93.
Cetani F, Pardi E, Vignali E, et al. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism. J Endocrinol Invest 2002, 25: 508–12.
Tamagno G, Carlo D, Martini, Rubello D, Fallo F, Sicolo. The early diagnosis of multiple endocrine neoplasia type 1(MEN1): A Case Report. J Endocrinol Invest 2004, 27: 878–82.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ozturk, M., Chiu, C.Y., Akdeniz, N. et al. Two novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1. J Endocrinol Invest 29, 523–527 (2006). https://doi.org/10.1007/BF03344142
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03344142